Literature DB >> 6372842

Pharmacokinetics of phosphomycin during haemofiltration.

C Fernandez Lastra, E L Mariño, A Dominguez-Gil, J M Tabernero, J Grande Villoria.   

Abstract

The pharmacokinetics of phosphomycin were studied in 10 adult patients with terminal renal impairment during a 4 h haemofiltration session. A single i.v. dose of 30 mg/kg of the antibiotic was administered to each patient at the beginning of the haemofiltration session. The half-life of the slow disposition phase (t 1/ 2z ) showed an average value of 4.05 +/- 1.77 h, much lower than that established in patients who did not undergo any purification techniques. Serum phosphomycin concentrations at the input and the output of the haemofilter at the end of the session were, respectively, 26.65 and 19.13 micrograms/ml. During haemofiltration, 64.90% of the original dose was eliminated. In this kind of patient we recommend a dose of 30 mg/kg at the beginning and at the end of each haemofiltration session for interfiltration periods of 48 h.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6372842      PMCID: PMC1463399          DOI: 10.1111/j.1365-2125.1984.tb02376.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Clinical pharmacology and in vitro activity of phosphonomycin.

Authors:  D G Kestle; W M Kirby
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

2.  Phosphonomycin, a new antibiotic produced by strains of streptomyces.

Authors:  D Hendlin; E O Stapley; M Jackson; H Wallick; A K Miller; F J Wolf; T W Miller; L Chaiet; F M Kahan; E L Foltz; H B Woodruff; J M Mata; S Hernandez; S Mochales
Journal:  Science       Date:  1969-10-03       Impact factor: 47.728

3.  Pharmacokinetics of fosfomycin during hemodialysis.

Authors:  F Dalet; G Bade; M Roda
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

4.  Blood and urinary concentrations of fosfomycin as a function of the renal function value.

Authors:  M Neuman; G Fluteau
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

5.  The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluid.

Authors:  C Fernandez Lastra; E L Mariño; A Dominguez-Gil; J M Tabernero; A Gonzalez Lopez; M Yuste Chaves
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

7.  Pharmacokinetics of cephacetrile in patients undergoing haemodialysis.

Authors:  A Dominguez-Gil; J M Lanao; J M Tabernero; J L Rodriguez Commes; S de Castro
Journal:  Eur J Clin Pharmacol       Date:  1979-08       Impact factor: 2.953

8.  Pharmacokinetics of cefoxitin during haemofiltration.

Authors:  M J Garcia; A Dominguez-Gil; J M Tabernero; M Diaz Molina
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Pharmacokinetics of cefamandole in patients undergoing hemodialysis.

Authors:  J A Campillo; J M Lanao; A Dominguez-Gil; J M Tabernero; F Rubio
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-09
  9 in total
  1 in total

Review 1.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.